Pharmaceutical giant Pfizer has reported a young boy has died due to cardiac arrest after receiving the company’s experimental gene therapy for Duchenne muscular dystrophy.
A Pfizer spokesperson told Reuters in an exclusive email, “A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study.”
Pfizer’s gene therapy trial is currently testing children two to three-year-olds who have Duchenne muscular dystrophy.
According to Johns Hopkins Medicine , Duchenne muscular dystrophy (DMD) “is caused by a genetic problem in producing dystrophin, a protein that protects muscle fibers from breaking down when exposed to enzymes.” BREAKING: A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday. – Stat News pic.twitter.com/qXeeRNApYQ — Insider Paper (@TheInsiderPaper) May 7, 2024 Per Reuters : A young patient died due to cardiac arrest after receiving Pfizer’s gene therapy being […]
Read the Whole Article From the Source: www.thegatewaypundit.com
Click this link for the original source of this article.
Author: The Gateway Pundit
This content is courtesy of, and owned and copyrighted by, https://discernreport.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.